Academic
Publications
Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons

Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons,10.1016/S0196-9781(99)00016-9,Peptides,John D Tompkins,Donald B Ho

Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons   (Citations: 5)
BibTex | RIS | RefWorks Download
Substance P (SP) evokes bradycardia that is mediated by cholinergic neurons in experiments with isolated guinea pig hearts. This project investigates the negative chronotropic action of SP in vivo. Guinea pigs were anesthetized with urethane, vagotomized and artificially respired. Using this model, IV injection of SP (32 nmol/kg/50 μl saline) caused a brief decrease in heart rate (−30 ± 3 beats/min from a baseline of 256 ± 4 beats/min, n = 27) and a long-lasting decrease in blood pressure (−28 ± 2 mmHg from baseline of 51 ± 5 mmHg, n = 27). The negative chronotropic response to SP was attenuated by muscarinic receptor blockade with atropine (−29 ± 9 beats/min before vs −8 ± 2 beats/min after treatment, P = 0.0204, n = 5) and augmented by inhibition of cholinesterases with physostigmine (−23 ± 6 beats/min before versus −74 ± 20 beats/min after treatment, P = 0.0250, n = 5). Ganglion blockade with chlorisondamine did not diminish the negative chronotropic response to SP. In another series of experiments, animals were anesthetized with sodium pentobarbital or urethane and studied with or without vagotomy. Neither anesthetic nor vagotomy had a significant effect on the negative chronotropic response to SP (F3,24 = 1.97, P = 0.2198). Comparison of responses to 640 nmol/kg nitroprusside and 32 nmol/kg SP demonstrated that the bradycardic effect of SP occurs independent of vasodilation. These results suggest that SP can evoke bradycardia in vivo through stimulation of postganglionic cholinergic neurons.
Journal: Peptides , vol. 20, no. 5, pp. 623-628, 1999
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...The effects of SP on the cardiac system can be blocked by atropine, a competitive antagonist of the muscarinic acetylcholine receptor, showing that it is mediated by the cholinergic nerves [23,25]...
    • ...It has been previously reported that the cardiovascular effects of SP [23,25], but not of NKA [18], could be prevented by atropine...

    Keld Fosgerauet al. Increased susceptibility to cardiovascular effects of dihydrocapcaicin...

Sort by: